laboratory equipment and services Healthcare and Medicine

Plant Mitochondrial Genome Tender

πŸ›οΈ MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV GERMANY
πŸ“„ Tender ID: 505694177 πŸ“… Published: 04 Jul 2024

πŸ“‹ Tender Overview

Plant Mitochondrial Genome Engineering: Technology Development And Application To Study Fundamental Aspects Of Mitochondrial Gene Expression
Plamiteng Has The Highly Ambitious Overall Objective To Make The Mitochondrial Genome Of Seed Plants Amenable To Genetic Engineering. The Project Consists Of Two Complementary Work Packages (Wps). In Wp1, Talen-Gdm, A Technology For Plant Mitochondrial Genome Editing Recently Developed By Us Will Be Used To Systematically Study Plant Mitochondrial Gene Expression In Vivo. The Focus Will Be On Translation Initiation And Translational Regulation In Mitochondria, The Mechanisms Of Which Are Currently Completely Unknown. In Wp2, Plamiteng Will Develop A Technology For Direct Genetic Transformation Of The Plant Mitochondrial Genome. The Mitochondrial Genome Is The Only Genome Of The Plant Cell That, Due To The Lack Of A Mitochondrion-Specific Selection System, Is Not Amenable To Transformation And Has Remained Recalcitrant To The Insertion And Expression Of Transgenes. Taking Advantage Of (I) Our Recent Construction Of A Mitochondrion-Specific Selectable Marker Gene, (Ii) The Generation Of A Dedicated Recipient Line For Mitochondrial Transformation, And (Iii) The Design Of A New Transformation Strategy (Referred To As Multivectorial Transformation) That Will Enable The Large-Scale Testing Of Expression Elements For Their Suitability To Drive The Expression Of Mitochondrial Transgenes In Vivo, Plamiteng Will Pursue The Development Of A Robust Technology For Transformation Of The Plant Mitochondrial Genome. The Possibility To Express Transgenes From Plant Mitochondrial Genomes Will Open Up Entirely New Opportunities In Both Basic And Applied Research, And Pave The Way To Harnessing The Enormous Potential Of Mitochondrial Biotechnology And Synthetic Biology.
Funded Under
European Research Council (Erc)
Total Cost
€ 2 500 000,00
Eu Contribution
€ 2 500 000,00
Coordinated By
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Ev
Germany
Start Date
1 July 2024
End Date
30 June 2029

Objective

PlaMitEng has the highly ambitious overall objective to make the mitochondrial genome of seed plants amenable to genetic engineering. The project consists of two complementary work packages (WPs). In WP1, TALEN-GDM, a technology for plant mitochondrial genome editing recently developed by us will be used to systematically study plant mitochondrial gene expression in vivo. The focus will be on translation initiation and translational regulation in mitochondria, the mechanisms of which are currently completely unknown. In WP2, PlaMitEng will develop a technology for direct genetic transformation of the plant mitochondrial genome. The mitochondrial genome is the only genome of the plant cell that, due to the lack of a mitochondrion-specific selection system, is not amenable to transformation and has remained recalcitrant to the insertion and expression of transgenes. Taking advantage of (i) our recent construc

πŸ” Key Information

πŸ“„
Tender Reference No.
505694177
πŸ“…
Publication Date
04 Jul 2024
πŸ’°
Estimated Value
EUR 250000000
🌐
Sector
laboratory equipment and services
πŸ“…
Deadline
30 Jun 2029
πŸ“
Notice Type
Projects
πŸ“
Location
Germany
πŸ“‘
Contract Duration
4 Years 11 Months 26 Days

πŸ“ Documents & Downloads

View All Documents β†’
# Document Name Type Action
2
T505694177.html
HTML

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
πŸ•’ Submission deadline
970
days remaining Β· 30 Jun 2029
πŸ”” Set Alert

🧭 Quick Facts

Authority MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV GERMANY
Country Germany
State / UT N/A
Tender Type Project Information
Currency EUR
Similar Tenders
Loading similar tenders…